Document Type
|
:
|
BL
|
Record Number
|
:
|
874921
|
Main Entry
|
:
|
Joseph, S., (Sonny)
|
Title & Author
|
:
|
Personality disorders : : new symptom-focused drug therapy /\ S. Joseph.
|
Publication Statement
|
:
|
London :: Routledge,, 2019.
|
Series Statement
|
:
|
Psychology library editions. Personality ;; volume 9
|
Page. NO
|
:
|
1 online resource (1 volume)
|
ISBN
|
:
|
0429027745
|
|
:
|
: 0429636741
|
|
:
|
: 0429639910
|
|
:
|
: 042964308X
|
|
:
|
: 9780429027741
|
|
:
|
: 9780429636745
|
|
:
|
: 9780429639913
|
|
:
|
: 9780429643088
|
|
:
|
0367136465
|
|
:
|
9780367136468
|
Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
Contents
|
:
|
Cover; Half Title; Title Page; Copyright Page; Original Half Title; Original Title Page; Contents; About the Author; Foreword; Preface; Acknowledgments; PART I: PERSONALITY DISORDERS AND CASE STUDIES; Chapter 1. Personality Disorders: General Clinical Concepts; General Diagnostic and Treatment Concepts; Symptom-Focused Treatment: The Medical Model; Rational Polypharmacy: Evolution in Psychiatric Drug Therapy; Chapter 2. Paranoid Personality Disorder; DSM-IV Criteria and Symptom Correlates
|
|
:
|
Clinical Cases 41 to 48Chapter 12. Personality Disorder, Not Otherwise Specified; Clinical Case 49; Chapter 13. Personality Change Due to a General Medical Condition (Axis I); Common General Medical Conditions That Can Lead to Personality Change; Clinical Case 50; PART II: CLINICAL PROFILES OF SELECTED PSYCHIATRIC DRUGS; Chapter 14. Clinical Profiles of Selected New Generation Antidepressants; Bupropion (Wellbutrin) and Bupropion SR (Wellbutrin SR); Fluoxetine (Prozac); Sertraline (Zoloft); Paroxetine (Paxil); Venlafaxine (Effexor); Fluvoxamine (Luvox); Nefazodone (Serzone)
|
|
:
|
Mirtazapine (Remeron)Clomipramine (Anafranil); Naltrexone (Revia, Trexan); Chapter 15. Clinical Profiles of Selected New Generation Antipsychotics; Risperidone (Risperdal); Clozapine (Clozaril); Effective Combinations Involving Clozapine; Discontinuation of Clozapine; Techniques to Detect or Minimize Serious Clozapine Side Effects; Starting Clozapine-To Hospitalize or Not; Olanzapine (Zyprexa); Sertindole (Serlect); Appendix A. Alphabetical Listing of Drugs by Generic Names, with U.S. Brand Names; Appendix B. Alphabetical Listing of Drugs by U.S. Brand Names, with Generic Names
|
|
:
|
Symptom Clusters in Paranoid Personality Disorder with Major Medication Options for the Particular ClusterSpecific Treatment Recommendations; Clinical Cases 1 to 4; Chapter 3. Schizoid Personality Disorder; DSM-IV Criteria and Symptom Correlates; Clinical Cases 5 to 8; Chapter 4. Schizotypal Personality Disorder; DSM -IV Criteria and Symptom Correlates; Clinical Cases 9 to 16; Chapter 5. Antisocial Personality Disorder; DSM-IV Criteria and Symptom Correlates; Clinical Cases 17 to 19; Chapter 6. Borderline Personality Disorder; DSM -IV Criteria and Symptom Correlates
|
|
:
|
Treating and Working with Suicidal PatientsClinical Cases 20 to 30; Chapter 7. Histrionic Personality Disorder; DSM -IV Criteria and Symptom Correlates; Clinical Case 31; Chapter 8. Narcissistic Personality Disorder; DSM-IV Criteria and Symptom Correlates; Clinical Cases 32 to 35; Chapter 9. Avoidant Personality Disorder; DSM -IV Criteria and Symptom Correlates; Clinical Case 36; Chapter 10. Dependent Personality Disorder; DSM-IV Criteria and Symptom Correlates; Clinical Cases 37 to 40; Chapter 11. Obsessive-Compulsive Personality Disorder; DSM -IV Criteria and Symptom Correlates
|
Subject
|
:
|
Personality disorders.
|
Subject
|
:
|
HEALTH FITNESS-- Diseases-- General.
|
Subject
|
:
|
MEDICAL-- Clinical Medicine.
|
Subject
|
:
|
MEDICAL-- Diseases.
|
Subject
|
:
|
MEDICAL-- Evidence-Based Medicine.
|
Subject
|
:
|
MEDICAL-- Internal Medicine.
|
Subject
|
:
|
Personality disorders.
|
Dewey Classification
|
:
|
616.8581
|
LC Classification
|
:
|
RC554.J67P47 2019
|